PROGUBTA

PROGUTBA bundles the different antimicrobial functions of the SCFA’s ( short chain fatty acids) enriched with unique combination of MCFA’s (medium chain fatty acids) which allows for a wide antimicrobial spectrum throughout the gastro intestinal tract. SCFA’s lower the stomach pH, improving digestion and increa­sing the barrier function against harmful microbes. They have a bactericidal effect in an acidic environment, mostly against G-bacteria. MCFA’s facilitate and broaden the action of SCFA in the stomach and intestines and - more particularly lauric acid (C:12) -, have a bactericidal effect in the intestines against the G+bacteria (i.e. Clostridium perfringens). PROGUTBA reduces the infection pressure of pathogen microbes through the entire GIT, whilst promoting the lactic acid producing bacteria (LAB). The result: a healthy microbial status or EUBIOSIS, which overcomes the problems of sub-clinical necrotic enteritis.